syngo.MR OncoCare

syngo.MR OncoCare
 
Try

Examples for clinical application


Monitoring bone marrow metastases treatment

Histogram analysis of whole-body diffusion-weighted images and ADC maps has been documented to be a powerful tool to monitor response to treatment in skeletal therapy.


Earlier assessment of response to TACE therapy

Volumetric functional MR assessment is documented to predict TACE therapy response after one month1, where the currently available imaging criteria (morphology-based) assess therapy response after six months, earliest2.

The benefits are two-fold: Treatment path optimization and savings of unnecessary treatment costs.

General Requirements

System

Minimum Software Version

syngo.via VB10
syngo.MR Onco

Other

Please Note: Additional technical pre-requisites may apply. Upon receiving your request, your local Siemens representative will clarify whether your system meets the requirements.

Related Products, Services & Resources

1Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy Radiology. 2013;268:431-9

2Hepatocellular Carcinoma: Response to TACE Assessed with Semiautomated Volumetric and Functional Analysis of Diffusion-weighted and Contrast-enhanced MR Imaging Data; Radiology: 2011;260:752-761